Published in Mov Disord on February 15, 2007
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ (2010) 5.19
Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity. Nat Genet (2009) 3.06
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology (2007) 1.97
Prospective study of statin use and risk of Parkinson disease. Arch Neurol (2012) 1.76
Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Dis Model Mech (2012) 1.31
Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Med (2014) 1.31
Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease. J Neurochem (2008) 1.24
Statin use and the risk of Parkinson disease. Neurology (2008) 1.10
Targets for neuroprotection in Parkinson's disease. Biochim Biophys Acta (2008) 1.08
Prospects of statins in Parkinson disease. Neuroscientist (2011) 1.07
Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Exp Neurol (2009) 1.04
Transcriptional activation of low-density lipoprotein receptor gene by DJ-1 and effect of DJ-1 on cholesterol homeostasis. PLoS One (2012) 0.94
Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study. Mov Disord (2015) 0.93
Statin use and Parkinson's disease in Denmark. Mov Disord (2010) 0.93
Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease. Mov Disord (2007) 0.92
Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics (2014) 0.92
Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease. Cell Death Differ (2011) 0.90
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies. J Neurol (2012) 0.88
Serum cholesterol and the progression of Parkinson's disease: results from DATATOP. PLoS One (2011) 0.86
Association of fibrinogen with Parkinson disease in elderly Japanese-American men: a prospective study. Neuroepidemiology (2009) 0.84
Serum cholesterol and nigrostriatal R2* values in Parkinson's disease. PLoS One (2012) 0.83
Total cholesterol and the risk of Parkinson's disease: a review for some new findings. Parkinsons Dis (2009) 0.82
Novel subcellular localization for α-synuclein: possible functional consequences. Front Neuroanat (2015) 0.80
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives. Int J Mol Sci (2016) 0.80
Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis. PLoS One (2016) 0.80
Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration. J Neural Transm (Vienna) (2009) 0.80
APOE and LRPAP1 gene polymorphism and risk of Parkinson's disease. Neurol Sci (2014) 0.79
Lipid dysfunction and pathogenesis of multiple system atrophy. Acta Neuropathol Commun (2014) 0.79
Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study. J Neurol Neurosurg Psychiatry (2015) 0.76
Integrated molecular landscape of Parkinson's disease. NPJ Parkinsons Dis (2017) 0.76
Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease. Biomed Res Int (2013) 0.75
Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's Disease. Aging Dis (2016) 0.75
Reply: Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent? Mov Disord (2010) 0.75
Statin Use and Its Association with Essential Tremor and Parkinson's Disease. Neuroepidemiology (2016) 0.75
Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk. Front Neurol (2017) 0.75
Organophosphate pesticides and PON1 L55M in Parkinson's disease progression. Environ Int (2017) 0.75
The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration. Metab Brain Dis (2017) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet (2000) 6.61
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ (1989) 2.96
Research diagnostic criteria for Parkinson's disease. Adv Neurol (1990) 2.28
Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol (2004) 2.09
Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol (2002) 1.86
Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res (1992) 1.83
Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol (2005) 1.76
Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation (1995) 1.73
Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol (2004) 1.72
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA (1994) 1.71
Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol (1994) 1.70
Epidemiologic studies of Parkinson's disease. 3. A community-based survey. Am J Epidemiol (1972) 1.68
Evidence for inflammation as a cause of hypocholesterolemia in older people. J Am Geriatr Soc (1995) 1.49
Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology (2005) 1.31
APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology (2004) 1.30
Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies. Adv Neurol (2003) 1.27
Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol (2003) 1.19
Neuroprotective properties of statins. Pharmacol Rep (2005) 1.08
Parkinson's disease, stroke, and related epidemiology. Mov Disord (2005) 0.98
Changes in serum cholesterol level and mortality: a 30-year follow-up. The Finnish cohorts of the seven countries study. Am J Epidemiol (1994) 0.95
Do spinal cord injuries adversely affect serum lipoprotein profiles? Mil Med (2003) 0.89
Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease. Biochem Med Metab Biol (1993) 0.89
Causes of hypocholesterolemia. Coron Artery Dis (1993) 0.87
Long-term evolution of blood lipid profiles and glycemic levels in patients after spinal cord injury. Spinal Cord (2003) 0.84
Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering. Am J Cardiol (2002) 0.83
[Lipid metabolism parameters in patients with multi-infarct dementia and Alzheimer's type dementia]. Neurol Neurochir Pol (1996) 0.81
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Neighborhood characteristics associated with the location of food stores and food service places. Am J Prev Med (2002) 13.39
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87
Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60
Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther (2006) 7.03
The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87
Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis (2008) 5.85
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77
Adjustment of systematic microarray data biases. Bioinformatics (2004) 5.22
Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA (2002) 5.07
Metal oxide gas sensors: sensitivity and influencing factors. Sensors (Basel) (2010) 4.89
Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health (2006) 4.73
A robust toolkit for functional profiling of the yeast genome. Mol Cell (2004) 4.69
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell (2004) 3.91
Preventable drug-related hospital admissions. Ann Pharmacother (2002) 3.78
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
Young age at first sexual intercourse and sexually transmitted infections in adolescents and young adults. Am J Epidemiol (2005) 3.69
SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol (2009) 3.55
Illustrating bias due to conditioning on a collider. Int J Epidemiol (2009) 3.54
Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet (2005) 3.48
First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res A Clin Mol Teratol (2010) 3.45
The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis (2009) 3.44
Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis (2006) 3.17
Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. J Infect Dis (2011) 3.16
The ongoing tyranny of statistical significance testing in biomedical research. Eur J Epidemiol (2010) 3.10
HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS (2006) 3.05
Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med (2002) 2.99
Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol (2003) 2.93
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol (2008) 2.91
Pesticide exposure and risk for Parkinson's disease. Ann Neurol (2006) 2.89
Living with p values: resurrecting a Bayesian perspective on frequentist statistics. Epidemiology (2013) 2.86
Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis (2007) 2.85
Use of ibuprofen and risk of Parkinson disease. Neurology (2011) 2.70
Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke (2005) 2.63
HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention. J Acquir Immune Defic Syndr (2011) 2.49
Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis (2006) 2.44
Frequent detection of acute primary HIV infection in men in Malawi. AIDS (2004) 2.43
Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics (2003) 2.38
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet (2011) 2.28
Prevalence of HIV infection among young adults in the United States: results from the Add Health study. Am J Public Health (2006) 2.17
Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions. BMC Public Health (2004) 2.03
The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effects. J Biochem Mol Toxicol (2014) 2.03
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 2.02
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01
A tale of two countries: rethinking sexual risk for HIV among young people in South Africa and the United States. J Adolesc Health (2011) 2.00
Evaluation of risk score algorithms for detection of chlamydial and gonococcal infections in an emergency department setting. Acad Emerg Med (2008) 1.98
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology (2007) 1.97
Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev (2009) 1.91
Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS (2007) 1.89
Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. J Infect Dis (2005) 1.88
Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality. Am J Epidemiol (2009) 1.87
Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis. J Thorac Oncol (2007) 1.86
Incarceration and risky sexual partnerships in a southern US city. J Urban Health (2007) 1.83
Older adults, chronic disease and leisure-time physical activity. Gerontology (2008) 1.83
Diabetes and risk of Parkinson's disease. Diabetes Care (2011) 1.80
HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? PLoS Med (2012) 1.76
Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology (2010) 1.75
Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch Pediatr Adolesc Med (2004) 1.71
A time-series analysis of air pollution and preterm birth in Pennsylvania, 1997-2001. Environ Health Perspect (2005) 1.70
Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol (2008) 1.69
A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011. Clin Infect Dis (2013) 1.67
Bounding causal effects under uncontrolled confounding using counterfactuals. Epidemiology (2005) 1.67
HIV testing and counseling leads to immediate consistent condom use among South African stable HIV-discordant couples. J Acquir Immune Defic Syndr (2013) 1.64
Polyethylene wear and acetabular component orientation. J Bone Joint Surg Am (2003) 1.62
Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev (2002) 1.62
Bone mineral density and dietary patterns in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr (2002) 1.61
Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. Neuropsychopharmacology (2006) 1.61
Timing and duration of incarceration and high-risk sexual partnerships among African Americans in North Carolina. Ann Epidemiol (2008) 1.60
The outdoor air pollution and brain health workshop. Neurotoxicology (2012) 1.60
Both low and high temperature may increase the risk of stroke mortality. Neurology (2013) 1.59
Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr (2002) 1.59
Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol (2002) 1.58
IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women. Cancer Epidemiol Biomarkers Prev (2009) 1.58
Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr (2007) 1.57
HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med (2012) 1.55
Multivitamin use and telomere length in women. Am J Clin Nutr (2009) 1.54
Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation. Sex Transm Dis (2004) 1.54
Quantitative ultrashort echo time (UTE) MRI of human cortical bone: correlation with porosity and biomechanical properties. J Bone Miner Res (2012) 1.53
Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis (2003) 1.52
Head injury and Parkinson's disease: a population-based study. Mov Disord (2012) 1.52
Improved estimation of controlled direct effects in the presence of unmeasured confounding of intermediate variables. Stat Med (2005) 1.51
Nonexperimental comparative effectiveness research using linked healthcare databases. Epidemiology (2011) 1.50
Early coital debut and associated HIV risk factors among young women and men in South Africa. Int Perspect Sex Reprod Health (2009) 1.49
Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. Am J Obstet Gynecol (2005) 1.49
"Toward a clearer definition of confounding" revisited with directed acyclic graphs. Am J Epidemiol (2012) 1.48
Measurement properties of the Activities-specific Balance Confidence Scale among individuals with stroke. Disabil Rehabil (2005) 1.46
Estimating personal exposures from ambient air pollution measures: using meta-analysis to assess measurement error. Epidemiology (2014) 1.45
Recreational physical activity and risk of Parkinson's disease. Mov Disord (2008) 1.45
Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology (2011) 1.45